0001461993-19-000051.txt : 20191025 0001461993-19-000051.hdr.sgml : 20191025 20191025125333 ACCESSION NUMBER: 0001461993-19-000051 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191017 FILED AS OF DATE: 20191025 DATE AS OF CHANGE: 20191025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lococo Ryan CENTRAL INDEX KEY: 0001792251 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35405 FILM NUMBER: 191168929 MAIL ADDRESS: STREET 1: C/O MELINTA THERAPEUTICS, INC. STREET 2: 44 WHIPPANY ROAD CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/ CENTRAL INDEX KEY: 0001461993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454440364 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 WHIPPANY ROAD CITY: MORRISTOWN STATE: NJ ZIP: 07963 BUSINESS PHONE: 908 617-1309 MAIL ADDRESS: STREET 1: 44 WHIPPANY ROAD CITY: MORRISTOWN STATE: NJ ZIP: 07963 FORMER COMPANY: FORMER CONFORMED NAME: CEMPRA, INC. DATE OF NAME CHANGE: 20120203 FORMER COMPANY: FORMER CONFORMED NAME: Cempra Holdings, LLC DATE OF NAME CHANGE: 20090414 3 1 wf-form3_157202238312598.xml FORM 3 X0206 3 2019-10-17 0 0001461993 MELINTA THERAPEUTICS, INC. /NEW/ MLNT 0001792251 Lococo Ryan C/O MELINTA THERAPEUTICS, INC. 44 WHIPPANY ROAD MORRISTOWN NJ 07960 0 1 0 0 Chief Operating Officer Melinta Common Stock 41.25 2028-06-13 Melinta Stock Option (right to buy) 5620.0 D Melinta Common Stock Melinta Restricted Stock Units 100000.0 D Shares will vest 25% on the first anniversary of the award, June 14, 2019, then ratably over the following 36 months. The restricted stock units will vest in equal semi-annual installments over the two year period following May 16, 2019, subject to continued service with the Issuer through the applicable vesting date. /s/ Russell E Causey, by Power of Attorney 2019-10-25 EX-24 2 melinta-lococopoa.htm POWER OF ATTORNEY

POWER OF ATTORNEY

      Know all by these presents, that the undersigned hereby constitutes and appoints each of Susan Blum and Russell Causey, and each of them acting alone, signing singly, as the undersigned's true and lawful attorney-in-fact to:  (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer of Melinta Therapeutics, Inc. (the "Company''), Forms 3, 4 and 5, and Update Passphrase Acknowledgement   (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules promulgated  thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5, and Update Passphrase Acknowledgement (and any
amendments thereto) and to file timely such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

      The undersigned hereby grants to each such attorney-in-fact full power and authority to  do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned  acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the 1934 Act.

      This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5, and Update Passphrase Acknowledgement with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned, in a signed writing delivered to each of the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24th day of October 2019.



                             /s/ Ryan Lococo
                             Ryan Lococo